Bridgeway Capital Management’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
MBAM
Bridgeway Capital Management's OPRX Position: Q3 2026 in Review
Bridgeway Capital Management opened a new position in OptimizeRx (OPRX) in Q3 2026: 30,000 shares worth $250K. The stake represents ﹤0.01% of the portfolio and ranks #965 among its holdings. This is a return to the name: Bridgeway Capital Management previously reported a position in OPRX as recently as Q1 2026.
Bridgeway Capital Management first reported a position in OPRX in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.78M in Q4 2023. 103 funds tracked by Wall St. Rank hold OPRX as of Q3 2026.
- Bridgeway Capital Management held 30,000 shares of OptimizeRx worth $250K as of Q3 2026.
- OptimizeRx was a new Bridgeway Capital Management position in Q3 2026.
- OptimizeRx made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q3 2026, its #965 holding.
- Bridgeway Capital Management first reported a position in OptimizeRx in Q3 2023 and has held it in 12 quarters since.
- Bridgeway Capital Management's OptimizeRx position peaked at $1.78M in Q4 2023.
- 103 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2026.
Based on Bridgeway Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.